The Devil is in the Detail: A Rare H-Bonding Motif in New Forms of Docetaxel
暂无分享,去创建一个
[1] R. Dinnebier,et al. Small molecule, big difference: the role of water in the crystallization of paclitaxel. , 2013, Journal of pharmaceutical sciences.
[2] U. Jahn,et al. 4-(1-Haloalkyl)-3-nitrotetrahydrofurans as versatile scaffolds for the synthesis of diversely functionalized tetrahydrofurans , 2012 .
[3] A. Fortes,et al. Advances in the synthesis of homochiral (-)-1-azafagomine and (+)-5-epi-1-azafagomine. 1-N-phenyl carboxamide derivatives of both enantiomers of 1-azafagomine: Leads for the synthesis of active α-glycosidase inhibitors. , 2011, The Journal of organic chemistry.
[4] A. Rajbanshi,et al. Hydrogen-bond driven assembly of a molecular capsule facilitated by supramolecular chelation. , 2011, Chemical communications.
[5] T. Kar,et al. Structural elucidation, Hirshfeld surface analysis and quantum mechanical study of para-nitro benzylidene methyl arjunolate , 2011 .
[6] Chien-Hung Yeh,et al. Scalable synthesis of cortistatin A and related structures. , 2011, Journal of the American Chemical Society.
[7] Yaping Xue,et al. Formal total synthesis of (±)-estrone via the furano diene approach. , 2011, The Journal of organic chemistry.
[8] Bo B. Iversen,et al. Three new co-crystals of hydroquinone: crystal structures and Hirshfeld surface analysis of intermolecular interactions , 2010 .
[9] Richard J. Gildea,et al. OLEX2: a complete structure solution, refinement and analysis program , 2009 .
[10] Anthony L. Spek,et al. Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.
[11] Dylan Jayatilaka,et al. Hirshfeld surface analysis , 2009 .
[12] Ning Shan,et al. The role of cocrystals in pharmaceutical science. , 2008, Drug discovery today.
[13] J. Bernstein,et al. An Alternate Crystal Form of Gabapentin: A Cocrystal with Oxalic Acid , 2008 .
[14] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[15] D. Grant,et al. Structural characterization of an anhydrous polymorph of paclitaxel by solid-state NMR. , 2007, Physical chemistry chemical physics : PCCP.
[16] Geneviève Aubert,et al. Novel C2-C3' N-peptide linked macrocyclic taxoids. Part 2: synthesis and biological activities of docetaxel analogues with a peptide side chain at C2 and their macrocyclic derivatives. , 2007, Bioorganic & medicinal chemistry.
[17] Jason C. Cole,et al. DASH: a program for crystal structure determination from powder diffraction data , 2006 .
[18] J. Verweij,et al. Clinical Pharmacokinetics of Docetaxel , 2006, Clinical pharmacokinetics.
[19] Jianmin Chen,et al. Crystallographic determination of stereochemistry of biologically active 2'',3''-dibromo-7-epi-10-deacetylcephalomannine. , 2005, Bioorganic & medicinal chemistry letters.
[20] M. Spackman,et al. Novel tools for visualizing and exploring intermolecular interactions in molecular crystals. , 2004, Acta crystallographica. Section B, Structural science.
[21] Michael J Cima,et al. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.
[22] C. Daiguebonne,et al. Docetaxel (Taxotere® Trihydrate) Forms: Crystal Structure Determination from XRPD & XRSCD Data , 2004 .
[23] J. Cline,et al. Fundamental Parameters Line Profile Fitting in Laboratory Diffractometers. , 2004, Journal of research of the National Institute of Standards and Technology.
[24] Anthony L. Spek,et al. Journal of , 1993 .
[25] Alan A. Coelho,et al. Indexing of powder diffraction patterns by iterative use of singular value decomposition , 2002 .
[26] M. Spackman,et al. Fingerprinting intermolecular interactions in molecular crystals , 2002 .
[27] J. Snyder,et al. The binding conformation of Taxol in β-tubulin: A model based on electron crystallographic density , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] L. Rivory,et al. Clinical Pharmacokinetics of Docetaxel , 1999, Clinical pharmacokinetics.
[29] M. Spackman,et al. Hirshfeld Surfaces: A New Tool for Visualising and Exploring Molecular Crystals , 1998 .
[30] P. G. Byrom,et al. A novel definition of a molecule in a crystal , 1997 .
[31] Philip R. Cohen,et al. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere). , 1993, Cancer treatment reviews.
[32] E. Oldfield,et al. Methods for computing nuclear magnetic resonance chemical shielding in large systems. Multiple cluster and charge field approaches , 1993 .
[33] D. Kingston,et al. The chemistry of taxol. , 1991, Pharmacology & therapeutics.
[34] D. Guénard,et al. Structure of a synthetic taxol precursor: N-tert-butoxycarbonyl-10-deacetyl-N-debenzoyltaxol , 1990 .
[35] N. Bischofberger,et al. Photochemical Reactions. 149th Communication. Photochemistry of 7,8‐dihydro‐4‐hydroxy‐β‐ionone and derivatives , 1988 .
[36] Armel Le Bail,et al. Ab-initio structure determination of LiSbWO6 by X-ray powder diffraction , 1988 .
[37] M. Wani,et al. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemia and antitumor agent from , 1971 .
[38] A. McPhail,et al. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.
[39] H. Rietveld. A profile refinement method for nuclear and magnetic structures , 1969 .